Article
Cell Barcoding Reveals Lineage-dependent Outcomes in hiPSC Cardiac Differentiation
2025-12-16
Abstract excerpt
<h4>ABSTRACT</h4> Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have potential applications in treating cardiovascular disease but are currently limited in their clinical translation. A primary limitation is the poor clinical scalability of hiPSC-CMs, with the heterogeneity of hiPSC cardiac differentiation significantly contributing to this limitation. We hypothesize that clinical scalabi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f2a4b54-b12f-52f0-b585-e2de1cb2349d
- DOI
- 10.64898/2025.12.12.694049
